United States: Illinois

Firms: litigation

  • Kirkland & Ellis LLP
  • Sidley Austin LLP
  • Winston & Strawn LLP 
  • Bartlit Beck Herman Palenchar & Scott
  • Brinks Gilson & Lione
  • DLA Piper
  • Green Griffith & Borg-Breen LLP
  • Jenner & Block LLP
  • Latham & Watkins LLP
  • McAndrews, Held & Malloy Ltd 
  • Morgan, Lewis & Bockius LLP
  • Paul Hastings LLP
  • Perkins Coie LLP
  • Quinn Emanuel Urquhart & Sullivan LLP
  • Rakoczy Molino Mazzochi Siwik LLP
  • Steptoe & Johnson LLP
  • Arnold & Porter Kaye Scholer LLP
  • Baker & Hostetler LLP
  • Banner Witcoff
  • Greenberg Traurig LLP
  • Haynes and Boone LLP
  • Leydig, Voit & Mayer, Ltd
  • Locke Lord LLP
  • Marshall Gerstein & Borun LLP
  • Mayer Brown
  • McDermott Will & Emery
  • McDonnell Boehnen Hulbert & Berghoff LLP 
  • Polsinelli PC
  • Schiff Hardin LLP
  • Taft Stettinius & Hollister LLP

Firms: prosecution

Firms: transactions

Arnold & Porter Kaye Scholer LLP

Arnold & Porter has been one of the highest achievers in US patent litigation in recent years: its seasoned lead counsel put in textbook performances in impactful cases to get great outcomes for clients. Looking to continue this form, it added a hugely capable strike force in Chicago in August 2020 by recruiting Christopher Renk and Michael Harris from Banner Witcoff. Adept at handling all types of IP cases in all forums, they act for discerning players such as Nike, which they have successfully represented in numerous suits – including a recent Federal Circuit affirmance of a favourable PTAB decision in a high-profile action filed by Adidas in a bid to invalidate patents directed to Nike’s famous FlyKnit technology.

Baker & Hostetler LLP

Accomplished patent litigation outfit BakerHostetler is a popular pick among in-house counsel when infringement cases threaten the bottom line. The references for locally based trial lawyers John Letchinger and Leif Sigmond are glowing: “John has an extraordinary mastery of the law, takes ownership of things and is timely, responsive, communicative, motivated, determined and respectful.” He has lately been kept busy on several patent licensing disputes. “Leif is a superb leader, excellent strategist and terrific client service guy. He is especially good at assessing people’s needs and helping them develop solutions to their problems.” He is currently acting for plaintiff Trading Technologies in district court litigation relating to patents covering specialised graphical user interface tools for electronic trading.

Banner Witcoff

Banner Witcoff has numerous USPs, including a rich history – 2021 is its 101st year; an exceptional hit rate in registering patents; market-leading designs expertise; and razor-sharp litigation and post-grant abilities. As a result, it can fulfil any patent need for any innovative company. Working across the contentious/non-contentious divide, the contingent ably serves as a one-stop shop in its hometown of Chicago. The versatile Binal Patel and Joseph Berghammer feature in both the prosecution and litigation tables, providing forward-thinking, risk-smart counsel on rights procurement and management alongside technically astute representation in disputes. Patel’s specialist industries are financial services, insurance, automotive and heavy equipment, with prestigious clients including Bank of America Corp. Berghammer plays a strong hand in the chemical, mechanical and electrical areas and is assisting YETI Coolers with a broad spread of patent and non-patent IP matters. The most experienced first-chair litigator on deck is Timothy Meece, a perspicacious strategist and nimble advocate. He takes the lead in defending the many patents of Lexmark International and is a vital cog in a large team of lawyers acting for Comcast.

Bartlit Beck Herman Palenchar & Scott

Acclaimed trial outfit Bartlit Beck is a repository of trust for the most commercially consequential and complex lawsuits. Perfectly capable of taking on the toughest patent disputes itself, but always happy to collaborate with other counsel as the occasion demands, the firm has an intense results focus that leads to high-quality, efficient representation. All the leading trial lawyers here challenge themselves with a diverse range of cases; but those with a strong concentration of patent and IP suits include Steven Derringer, Chris Lind and Scott McBride. Recent high-profile victories include a $137 million verdict for Meso Scale Diagnostics against Roche Diagnostics, masterminded by Derringer together with John Hughes.

Brinks Gilson & Lione

In patent litigation, Brinks has a lot of horsepower under the hood, which it harnesses to drive satisfying wins in headline-grabbing cases. Anchors on the life sciences side include Dominic Zanfardino and Laura Lydigsen – the former especially noted for his finely honed trial skills and the latter for her appellate expertise. Lydigsen partners dynamically with highly experienced former in-house counsel Kent Walker and Mark Remus on behalf of Amneal Pharmaceuticals and others; Lydigsen and Remus also formed a pairing that was instrumental in seeing Brinks named to Novartis’s Preferred Firm Programme in February 2020. Remus leans heavily into the pharmaceutical and biotechnology practice, but also litigates with dexterity in other areas such as electronics and heavy equipment. For high-technology cases, James Sobieraj is the pick of the bunch. Competitive and tenacious, he puts his shoulder to the wheel for clients and has a pristine record to show for his efforts. Of course, Brinks is celebrated for its all-round patent capabilities and is enthusiastically endorsed for prosecution; using state-of-the-art proprietary software tools, it procures patents and manages large portfolios with great efficiency. At the forefront of this practice are Joseph Hetz and Andrew Stover, who between them have prosecuted many thousands of patents in the United States and abroad. Electrical and computer innovation specialist Hetz is a “business-minded lawyer who keeps a strong focus on increasing value in a client’s portfolio”.  This commerciality is a trait shared by Stover, whose remit encompasses mechanical and medical technologies.

DLA Piper

The trial nous of Chicago-based lawyers Matthew Satchwell and Paul Steadman plays a vital role in elevating DLA Piper’s national patent litigation practice. Both lawyers distinguish themselves in the ITC, where their collectedness, dedication and speed pay dividends; but are also highly adept in other forums, including district courts around the country, as well as the PTAB. Some of their best work has been done in the automotive industry, though they are completely at ease with any type of mechanical or electrical technology.

Global IP Law Group LLC

When it comes to the monetisation of intellectual property, few firms in the world are as sophisticated as Global IP Law Group. It has added billions to clients’ pockets utilising the full breadth of its cultivated sales, enforcement, strategic counselling and valuation know-how. Ragnar Olson, Graham Gerst and David Berten form an elite line-up of professionals for those looking to extract maximum value from their intangible assets. Licensing ace Olson “knows everyone” and is “extremely thorough”. Gerst “delivers great economic results that surpass expectations” and is a “top-level litigator and negotiator with a uniquely deep knowledge of Section 101-related issues”. Berten, a former Kirkland & Ellis and Bartlit Beck lawyer, has sparkling credentials and leads the contentious practice; he has also orchestrated many eye-wateringly large transactions.

Green Griffith & Borg-Breen LLP

With Jessica Tyrus Mackay making her debut in the rankings this year, Green, Griffith & Borg-Breen now has its full complement of leading individuals included in the IAM Patent 1000. The group’s patent litigation experience – and especially its trial seasoning – is impressive, as is its technical wherewithal: the combination has proved instrumental in numerous notable successes on behalf of top life sciences companies. The set also does much for clients away from the courtroom in counselling them at a strategic level on infringement and other matters, which makes for a well-rounded, reliable service. Coming back to Mackay, sources endorse her as a “thorough pharmaceutical patent litigator who leaves no stone unturned”. She has recently been engaged, alongside Caryn Borg-Breen, in Hatch-Waxman litigation on behalf of Horizon Medicines against Alkem Laboratories, protecting Horizon’s valuable Duexis patent portfolio. PhD chemist Borg-Breen “really gets the science and is incredibly skilled as a lawyer”; she “makes herself available and is easy and enjoyable to work with”. Robert Green and Christopher Griffith, meanwhile, have been serving as lead counsel in a case for Assertio and APR Applied Pharma Research. Green has spent decades handling pharmaceutical litigation, giving him a level of strategic wisdom and gravitas that carries clients across the finish line. Fellow veteran lawyer Griffith has a rare depth of life sciences industry knowledge which underpins his advocacy.

Greenberg Traurig LLP

Home to high-calibre prosecutors and litigators, and offering a comprehensive suite of services, Greenberg Traurig’s (GT) Chicago patent team is microcosmic of the firm-wide practice. Appreciated from both a local and national perspective, GT is never less than utterly impressive; the scientific breadth and erudition of its specialists and the depth of their district court, ITC and post-grant know-how are particular head turners. A stellar pairing for prosecution and strategic counselling is formed by Gary Jarosik and Keith Jarosik. They take a huge load off the shoulders of in-house counsel in procuring and managing patent assets domestically and internationally, as well as representing them in post-grant proceedings. They understand the specific needs of clients and devote all their energies towards meeting them with rare efficiency. An important contributor both on the prosecution front and in litigation, global patent litigation co-chair Richard Harris brings cohesion to the practice, making him a vital contact for companies seeking a consistent service across all their matters. His duality of purpose heightens his strategic sense. Cut from similar cloth, Herbert Finn has a level of trial experience that creates a high threat value, helping him to bring about the swift and early resolution of many cases.

Haynes and Boone LLP

Haynes and Boone has made some astute moves in the recruitment market in the past two years. In 2020, it added former USPTO director Joseph Matal to its bench in DC and brought former Kirkland & Ellis partner Eugene Goryunov on board to serve as a local post-grant proceedings leader for the Chicago office. These additions follow those of Ralph Gabric and Laura Beth Miller, who put Haynes and Boone on the Chicago patent litigation map in 2019; the firm is thus building a solid local practice that is adding a valuable extra dimension to its superb national offering. Gabric and Miller are seasoned lead counsel who can make a compelling case in any forum and any technological discipline.

Jenner & Block LLP

There’s no shortage of demand for Jenner & Block in the patent litigation arena: the firm is hailed for its ability to take challenging cases to trial and win, and admired for its record on behalf of industry leaders in the high-technology and life sciences realms. Providing robust leadership to the team is Reginald Hill, whose “common-sense yet sophisticated approach to litigation and licensing strategy” is much appreciated: “In significant litigation, Reggie and his team provide an excellent, professional and cost-effective service and, more importantly, drive fantastic outcomes.” In one recent example, he prevailed for Schneider Electric USA against Power Analytics Corporation in a dispute over power distribution technologies for data centres, which culminated in the denial of a cert petition by the Supreme Court following a summary judgment of patent invalidity under Section 101 granted to Schneider. Terence Truax recently represented the same client in an action spanning the ITC, the District of Massachusetts and the Western District of Texas involving patents directed towards smart thermostats and heating, ventilation and air conditioning systems. Truax served a five-year term as managing partner until the end of 2019 and is now back to full focus as a well-rounded commercial, patent and antitrust litigator. For life sciences patent litigation, the person to call is chemistry PhD Louis Fogel, who scored a vital result for Coherus BioSciences in having a biosimilar litigation filed by Amgen dismissed.

K&L Gates LLP

K&L Gates earns expanded coverage in the IAM Patent 1000 for 2021 through its addition to the Illinois prosecution rankings. There’s solid depth to the local team – headlined by IP group leader Robert Barrett and Thomas Basso, who debuts in the individual listings – and a ton of great work being done for prestigious patrons. Barrett takes point in representing Nestlé on US patent matters and has done so for a decade, cultivating deep knowledge of the company which he translates into commercially tailored advice. Barrett’s exposure to wide-ranging strategic and transactional IP briefs has also served to enhance his business thinking. A big name in Japan, Basso is a fan favourite of the country’s technology and manufacturing companies, including Japan Display Inc and Murata Manufacturing; he’s a smooth communicator who adds further value through the training he hosts for them. Not limited to non-contentious assignments, the Chicago group is well equipped for litigation with James Shimota at bat. The “brilliant and creative attorney” is “as honest, hardworking and compassionate as they come” and “one of the top strategists in his profession”; he is also “an expert at marshalling the resources of his firm”.

Kirkland & Ellis LLP

Put simply, Kirkland & Ellis is one of the crème de la crème for hardcore patent litigation. Like firefighters on watch, its lawyers are always trial ready and bring an intensity to case preparation and development that serves them well both in the courtroom and in negotiations. The firm has a constellation of contentious stars across its California, DC, Chicago and New York offices, who collaborate effectively to give clients ultimate firepower. In Chicago, James Hurst is the name at the top of the fight card and virtually second to none in the country in terms of trial experience. He backs up his victories at the appellate level, too, recently capping a 2017 Delaware district court summary judgment win for Abbott in a suit brought by Enzo Life Sciences over DNA and RNA probe technologies used in medical testing with a Federal Circuit affirmance, which finalised the dispute following denial of a cert petition with the Supreme Court. Alongside him on this was DC appellate ace John O’Quinn and local colleague Amanda Hollis, who showcases impressive technical range, but acquits herself with distinction in pharmaceutical actions. Bryan Hales also relishes the cut and thrust of life sciences litigation. He recently acted for Eagle Pharmaceuticals, which sought to manufacture and market a competing drug to opposing party Eli Lilly’s Alimta chemotherapy treatment; he was brought in just a month before trial was due to commence, as testament to his life-saving capabilities. Russell Levine brings so much to Kirkland & Ellis, including trial and dispute resolution expertise, licensing wizardry, all-round strategic wisdom and valuable leadership and mentoring. Not to be left out on the highlight reel, he achieved a big Federal Circuit win for Syngenta against agrochemical manufacturer Willowood in a multi-layered patent and copyright dispute. Notably, Levine prevailed on the copyright issue despite the US government filing a statement of interest in support of Willowood’s position; furthermore, an issue arising on the patent side of the case was one of first impression regarding the imposition of a single-entity requirement under 35 USC Section 271(g). Transactions are another forte for the firm, as illustrated by the sophisticated deal work of heavyweights Seth Traxler, Neil Hirshman and Jeffery Norman. Traxler plays a dual role as co-head of the technology and IP transactions group and leader of the cybersecurity and data privacy practice; Hirshman leverages his technical background and is hailed for his intellect, speed and efficiency; while Norman is a leading authority on software.

Latham & Watkins LLP

“One of the biggest of the big hitters in patent litigation”, Latham fields a deep national bench of trial lawyers who excel at designing and executing winning strategies in bet-the-company cases. Pharmaceutical patent litigation is a stronghold for the team in Chicago and the focus of Kenneth Schuler and Marc Zubick, though both have broad contentious horizons. David Callahan anchors the local practice outside the life sciences, including in the semiconductor and automotive industries. Like his colleagues, Callahan frequently features in the cases that matter most and is a business-minded advocate with many accolades to his name.

Leydig, Voit & Mayer, Ltd

Leydig, Voit & Mayer is a premier boutique in Chicago, but has national and international reach through additional bases in Alexandria, Boulder, San Francisco, Frankfurt and Shenzhen. It draws judiciously on these resources to support innovative companies globally, whatever they are seeking to achieve through the procurement, enforcement or commercial deployment of patents. Business awareness is a hallmark of the entire group, but especially of key individuals such as Charles Mottier, a shareholder in the firm for over 35 years and an anchor of the prosecution, counselling and litigation practices. His versatility is a common trait across the team: former electrical engineer John Conklin has a deft portfolio management and licensing touch, as well as abundant lead trial counsel experience; John Kilyk artfully spans the contentious/non-contentious divide, with a refined skillset that lends itself well to post-grant proceedings, in which he is a compelling and highly sought-after representative; Michael Hartmann makes hay from his global patent knowledge in litigation; and Bruce Gagala and John Augustyn have also seen and done it all in patent practice, but are in their element in high-stakes litigation. Innovative approaches to thorny problems are the result of their effective collaboration.

Locke Lord LLP

Home to more than 40 USPTO-registered attorneys, Locke Lord is a high achiever in prosecution and portfolio management. However, its recognition in the Illinois chapter – in which it makes its debut for 2021 – stems from its facility for life sciences patent litigation. Chicago lawyer Keith Parr has played a leading role in pharmaceutical cases for more than 30 years; his combination of scientific, regulatory and business knowledge and trial skill makes him a redoubtable opponent. Steven Trybus is another prominent member of the life sciences group and an essential contributor to its courtroom and post-grant success. He has recently been representing The Broad Institute in a patent interference regarding CRISPR-Cas9 technology.

Marshall Gerstein & Borun LLP

The IAM Patent 1000’s individual rankings show just how deep Marshall Gertein’s patent practice runs: with multiple practitioners listed on each of the prosecution, litigation and transactions tables, it has achieved a feat managed by only one other firm in Chicago. What’s also striking is the kaleidoscopic breadth of technologies covered by the group, which is steeped in just about all innovative disciplines. The life sciences are a bastion of strength, thanks to highly skilled prosecutors such as Katherine Neville, Heather Kissling, Michael Muczynski and Jeffrey Sharp; deal lawyers Pamela Cox and Julie Watson; and trial lawyers John Labbé, Mark Izraelewicz and Kevin Flowers. Together they make for a formidable team that can realise any goal for their pharmaceutical and biotechnology clients. In the mechanical and electrical areas, there’s an abundance of talent too: electronics and software ace Randall Rueth, mechanical pro and former industry engineer and in-house counsel Michael Furmanek and fellow mechanics maven Jeremy Kriegel distinguish themselves in the areas of prosecution, portfolio management and counselling; Robert Gerstein lights up the stage as a deal lawyer, opinion giver and strategist; and Benjamin Horton – who comes from an automotive and semiconductors background – brings the heat in litigation.

Mayer Brown

When it comes to patents, Mayer Brown is best known for its contentious prowess: its premier trial lawyers consistently put in resonant performances in district courts, the Federal Circuit, the ITC and the PTAB, exhibiting particular adeptness in multi-faceted cases in which an understanding of the strategic interplay between different elements – trial and post-grant, for example – is key to success. One such lawyer is Chicago-based James Ferguson, who recently prevailed in a major patent dispute in Delaware on behalf of a global coalition of the 18 largest car manufacturers in Europe, Asia and the United States regarding ownership of a patented technology that measures blood alcohol level when a driver touches a car’s ignition button. Ferguson has led trials in many IP and non-IP cases, giving him a deep litigation playbook to draw from. Many of the firm’s patent lawyers have technical degrees and deploy their scientific erudition to support companies not just in litigation, but also in other ways. Vera Nackovic is a registered patent attorney who does an awesome job negotiating deals and developing global IP portfolios, as well as litigating, for life sciences companies. There’s a strong transactional focus to her present work, through which she has further refined her high-level industry and business understanding.

McAndrews, Held & Malloy Ltd 

Marrying skill in litigation, prosecution, portfolio management and counselling, McAndrews, Held & Malloy can be relied on for the right steer on any patent matter and for cogent all-round strategic IP planning. The boutique has a flair for litigation and trial work, which is the metier of many leading individuals, including seasoned advocates Edward Mas, Thomas Wimbiscus, Robert Surrette, Sharon Hwang and David Headrick. Mas is distinguished by his energy, tenacity and Federal Circuit expertise – all of which make the difference in the toughest disputes. He has been representing Abbott in litigation against Fischell, with various filings and successes – including in an inter partes review – yielding a settlement. Wimbiscus’s caseload is also typically high value, which is testament to the trust placed in him; his PTAB abilities are extremely well regarded. President of the firm Surrette litigates with poise both across the IP spectrum and at all stages of a matter: in the preparation phases, in court and in post-trial settings. Executive committee member Hwang masters all elements of her cases to gain an advantage when it’s time to stand up and present. Headrick – who has billion-dollar disputes on his CV – is brilliant at marshalling sprawling suits: he recently brought five inter partes review petitions on behalf of RTI Surgical challenging more than 100 claims of LifeNet’s composite spinal bone graft and soft tissue graft patents on 32 grounds, and successfully staying a litigation filed by LifeNet just seven or so months earlier. Invaluable contributions to the contentious effort come from numerous others for whom the ‘all-rounder’ description fits neatly. Among these is Deborah Laughton, who earns her IAM Patent 1000 stripes for the first time this year: “She’s a key member of a client-friendly group of excellent prosecution professionals. She is smart from a tactical perspective and her work is of a high standard and cost effective.” Procuring, enforcing and defending valuable patent rights, Peter McAndrews is in the thick of all the action, but shines as a global portfolio manager for leading names in medical equipment, semiconductors and other areas. Multi-jurisdictional work is also meat and drink to Troy Groetken, who supports big-name life sciences clients wherever they need him and gets results that have a business-transformative effect. Wil Rao has an international reputation for quality, founded on his foresighted strategic advice flavoured by unique litigation and prosecution insights. Rao recently handled a complex cross-border litigation with related PTAB proceedings alongside Christopher Carani, the set’s celebrated designs doyen. Many of the lawyers here have played a hand in the firm’s post-grant success, and all of them benefit from the presence of Herbert Hart – an invaluable consultant with a profound practical and academic understanding of PTAB proceedings.

McDermott Will & Emery

McDermott’s US patent litigation team is in the vanguard of the action: in the past five years, it has handled some 210-plus district court cases, 100-plus PTAB proceedings and numerous ITC investigations. Its work often has a cross-border component, for which its international resources prove invaluable. Helping to sustain a pristine record of success out of all of this are Chicago-based litigators Michael Chu and Charles McMahon. Local IP litigation group leader Chu “handles troubling infringement lawsuits masterfully and is particularly adept at managing unpredictable and difficult opposing parties”. McMahon calls on his rich trial and licensing know-how to achieve ideal outcomes in court cases and in settlement negotiations. McDermott also makes light work of prosecution and counselling assignments, many of which are fielded by global patent prosecution head Ahsan Shaikh, whose targeted approach to IP value creation secures his reputation as a supremely efficient lawyer; the money spent on his fees is a wise investment, not a cost.

McDonnell Boehnen Hulbert & Berghoff LLP 

Many companies entrust their most important matters to McDonnell Boehnen Hulbert & Berghoff (MBHB), their confidence inspired by its imposing phalanx of eminent trial lawyers. Paul Berghoff, for example, has acted for leading pharmaceutical manufacturers in their competitor battles for many years, with an enviable hit rate at the district court and appellate level to show for it. The same is true of Daniel Boehnen in his focused domains of electrical, mechanical, software, communications, chemical and medical technologies. Both are wise strategists and creative problem solvers who don’t back down when it’s necessary to draw lines in the sand. The firm is in pole position for post-grant action, too, with staunch leadership provided by Grantland Drutchas, whose tactical thinking is elevated by broad experience in litigation, licensing and counselling. Bradley Hulbert also effortlessly crosses over practice area divides; in terms of recent activities, the electrical group chair has developed a substantial portfolio for a multinational tool and diagnostics equipment producer while fending off patent assertion entities, and prosecuted extensively for a top software company. Software is the specialist subject of the commercially minded Michael Borella, whose former stint in corporate management saw him take charge of large groups of software engineers on multiple continents: “Mike engages in strategic patent prosecution with a view to increasing the value of clients’ portfolios, while minimising costs and ensuring no efforts are wasted. His ability to navigate complex issues around Section 101 and give pragmatic, useful advice is highly appreciated – he is a known and published expert in this area. Another interesting aspect of his background is that he is also an inventor.” Kevin Noonan and Donald Zuhn are the widely acclaimed leaders of MBHB’s incredibly well-developed life sciences patent procurement, protection and management practice.

Morgan, Lewis & Bockius LLP

There’s a high concentration of litigation and trial know-how in Morgan Lewis’s Chicago office, which is home to Michael Abernathy and fellow veteran first-chair trial lawyers Sanjay Murthy, Jason White and Jeffrey Gargano. Individually and collectively, they make a major contribution to a potent national patent litigation practice group that lights up district courts around the country, as well as the ITC and PTAB. Abernathy, White and Murthy showcased what they can accomplish as a unit by obtaining a complete victory for Praxair before the Federal Circuit in an ANDA case filed by Mallinckrodt Hospital Products IP, INO Therapeutics and Ikaria involving INOmax DSIR, Mallinckrodt’s second-best selling drug; the Federal Circuit upheld a District of Delaware decision invalidating multiple asserted patents under Section 101 and finding the remaining patents non-infringed by Praxair’s ANDA application for its nitric oxide delivery system. Impact cases such as this are in the safest of hands with them. IP disputes practice co-leader Abernathy “demonstrates practical leadership, gives crisp advice that is always well received and is brilliant at presenting”. Gargano also garners applause as a “great strategic thinker”, which he leverages in counselling his clients – including numerous Chinese companies looking to gain a foothold in the United States – on broad IP maters and as a predominantly pharmaceutical-focused litigator.

Nixon Peabody LLP 

“Nixon Peabody is great to work with: it has a number of exceptional advocates who are well supported by great associates. All the lawyers there are diligent and focused on putting their clients in the most advantageous position.” Flying the firm’s flag high in Chicago is Daniel J Burnham, a “proactive and responsive partner who handles urgent litigations with skill, while giving smart recommendations on business strategy”. A truly well-rounded lawyer, he is also “integral to company success in prosecution and post-grant proceedings”. “Dan has a fabulous legal mind and is cost conscious and always willing to be flexible around fee arrangements. His skills are matched by his genuine personality, sense of humour and customer-focused approach.” Janet M Garetto also impresses for her versatility: she handles patent and brand matters with aplomb, making her the ideal fit for those with diverse portfolios seeking a consistent approach to their intellectual property. Her advice is directed towards business as much as legal matters – and all the more valuable for it.

Paul Hastings LLP

Paul Hastings is a prime destination for globally impactful IP disputes: with litigators standing by in the United States, Europe and Asia, it is ideally positioned in terms of resources; while its maturity of approach chimes with companies faced with the sternest tests. Earning its first berth in the IAM Patent 1000 Illinois rankings for 2021, the firm has a hero in Chicago in Robert Unikel, the architect and implementer of prize-winning strategies on behalf of many industry titans, who ascends to the gold tier this year. Recent work on behalf of Google and Motorola Mobility against ContentGuard attests to his remarkable abilities as a litigator. In 2015 he won an Eastern District of Texas jury verdict – affirmed on appeal in 2017 – of non-infringement by Google and Samsung on five patents relating to digital rights management technology, for which ContentGuard was seeking damages of more than $500 million; he then invalidated the patent claims that ContentGuard had asserted against Google and its Android partners in covered business method (CBM) review proceedings, in the course of which he won two further appeals – one against the institution of the CBM and another, in May 2020, against the PTAB’s decision in it.

Perkins Coie LLP

Perkins Coie may not be a headline act in Chicago in the same way as in Seattle, for example, but it nonetheless has a solid foothold in the city, with a patent team that exemplifies the best of what the wider organisation offers more broadly. Covering all bases, the local office is home to firmwide prosecution and counselling practice chair David Fournier; seasoned trial lawyers Douglas Sawyer and Adam Marchuk; ITC ace James Coughlan; and transactions whizz Marcelo Halpern. Fournier hails from a clinical research background, giving him an insider’s perspective on the drug development process; his life sciences industry knowledge translates into highly practical, strategic advice on global portfolio management. Sawyer attracts warm praise from high-level private practitioners and the C-suite: alike “Doug is a go-to for running and winning complicated patent assertion campaigns and litigations. He has a great sense of humour and is brilliant to work with. He understands the business value of his actions and puts his focus on where he can add value.” Both Sawyer and Marchuk handle a diverse range of cases – including patent, trade secret, false advertising and unfair competition actions – through which they have developed refined advocacy skills. Coughlan co-chairs the ITC practice and splits his time between Chicago and DC; linking up with colleagues in California and Texas, he recently won an initial determination of no violation of Section 337 in a three-patent infringement investigation relating to garage door and gate operator technology – a matter which put everything on the line for client Nortek Security & Control. With an affinity for all kinds of emerging technologies, especially blockchain, Halpern is a smooth broker of IP and technology-driven deals for his diverse clientele, including a top software company.

Polsinelli PC

No longer lacking in name recognition, Polsinelli is a widely admired firm with real clout in all facets of patent practice. Much of the credit for its expansion and market ascent in recent years is owed to individuals such as Gary Hood, who joined as chair of IP litigation a decade ago and has served on the board since December 2019. Hood inspires and attracts clients and talented laterals through his sterling performances in pharmaceutical litigation, as both a strategic case developer and a courtroom advocate. He’s a true team player who makes optimum use of Polsinelli’s resources and is always looking to support those around him.

Quinn Emanuel Urquhart & Sullivan LLP

“Quinn Emanuel’s lawyers are smart, appropriately aggressive and very strategic in their approach – and they never get out-argued or out-briefed on a matter. Their goal is to win, whatever that means to any particular client; and they remain conscious of the spend involved to accomplish their wins, putting the appropriate number of lawyers on cases.” Holding the fort in Chicago, David Nelson has an unbelievable level of trial experience and co-chairs the national IP litigation practice.

Rakoczy Molino Mazzochi Siwik LLP

For generic drug manufacturers, Rakoczy Molino Mazzochi Siwik is a godsend; the prolific life sciences patent litigation boutique has handled several hundred Hatch-Waxman and Biologics Price Competition and Innovation Act suits since opening its doors in 2004, giving it a major advantage and a rich playbook to utilise for the next few hundred cases. At the forefront of the practice, William Rakoczy, Paul Molino and Deanne Mazzochi understand perfectly what clients need them to do, and have all the litigation and trial skills and technical, regulatory, IP and competition know-how to get results of fundamental importance to business success. They also have a gift for talent development, as shown by the rise to fame of fellow litigator Eric Hunt, who joined as a summer associate in the year of the ensemble’s founding and has served as partner for more than five years. One source comments: “Eric is easily one of my favourite lawyers and a go-to for reality checks regardless of the question at hand. He is always available and ready to dig in to the meatiest legal and business issues; he provides balanced, real-world counsel. I am proud to put him in front of my board of directors.” He makes his sophomore appearance in the guide this year; while Lara Fitzsimmons debuts as a leading regulatory counselling and deal lawyer. She is a vital cog in the firm’s litigation efforts thanks to her facility for settlement negotiation, which she flexes within a broader transactional practice.

Schiff Hardin LLP

Resonating in the pharmaceutical world, the name of Schiff Hardin is closely associated with victory on the generic side of Hatch-Waxman litigation. The team is paced by Imron Aly, a “renowned patent litigator with a unique ability to break down the most complex scientific concepts and build strong litigation positions. Brilliant at drafting briefs as well as in oral arguments, he is wonderfully effective in cross-examining prominent figures in the scientific community. He is a vigorous advocate with decades of top-level experience”. Also fulfilling a leadership function is Sailesh Patel, a fellow trial dynamo who gets everything right, whether designing strategies, selecting experts, coordinating teams of lawyers inside and outside his firm, or arguing in court. Tasked with challenging matters, Patel is representing Aurobindo Pharma in seeking to introduce a generic version of Pfizer’s Ibrance breast cancer therapy. Whether pairing up with Aly and/or Patel or running cases himself, Kevin Nelson also shines; he marries fine-grained regulatory knowledge with a special aptitude for biosimilar litigation.

Sidley Austin LLP

Sidley Austin packs a mighty punch in patent litigation and is an essential resource for the most mission-critical competitor disputes. The 25 partners in its group collaborate well within and across offices in a way that enhances efficiency – the right people are put on cases based on skills and experience, rather than location, bringing increased focus to case preparation and delivery. Unbeatable Supreme Court and Federal Circuit advocacy is another key differentiator for the organisation, ensuring that trial wins don’t fall away due to a lack of preparedness for appeals. One recent highlight in which these strengths came into play saw Stephanie Koh, Thomas Rein and Constantine Trela score an important result for CalAmp Corporation in appealing a decision that it had wilfully infringed four Omega patents – arising from a trial overseen by a different firm – and then handling a retrial in which infringement was narrowed down and deemed not wilful; post (re)trial motions filed by Omega seeking a trebled ongoing royalty rate, among other things, were subsequently denied, adding gloss to the outcome thus far. Koh serves as Chicago IP litigation leader, Rein as global leader and Trela as a key member of the Supreme Court and appellate group, which he founded. In terms of effective cross-state connections, the link between Richard Cederoth and San Francisco-based Mike Bettinger is a strong one; Cederoth is an A-lister not just of Sidley’s team, but of the wider US patent litigation market.

Steger IP, LLC 

A coal-and-ice partner to those seeking the best in patent transactions and monetisation support, Steger IP was only founded in 2018, but is already lighting up the patent world. It has a gift for ascertaining the untapped value in high-spec patent portfolios and then getting huge returns on it; the team looks way beyond simply narrowing down assets to assert in litigation. The ensemble is the brainchild of superlative strategist Steven Steger, a former chief IP counsel and “game changer who is assembling a world-class team”. In an inspired move, he recently recruited Elizabeth Rudersdorf, one of the most organised deal drivers that a client could dream of; her work – such as managing claim charting activity and outreach to potential buyers – is never less than flawless. She acts as outside general counsel to Allied Inventors and oversees the monetisation of its patent portfolio – a task that, in the past year, has seen her lead on dozens of deals involving hundreds of patents in areas such as augmented reality, social networking and automotive and financial technology.

Steptoe & Johnson LLP

“From an in-house perspective, Steptoe checks all the boxes. Its name carries a great reputation; it is responsive and service minded, and also full of great talent.” Two of its Chicago members who distinguish themselves are John Abramic and Jay Nuttall: they have “the perfect blend of business sense and legal knowledge”, and are “willing to work with clients with respect to budgets”. “They deliver on their word and deserve all the praise they get for their patent litigation and post-grant proceedings representation.” Both are vital components of a high-functioning practice group that staffs seamlessly across offices to secure positive results in high-stakes cases. Capitalising on the support around him in this way, Thomas Filarski thrives in the fray life sciences patent litigation and is regularly retained by Sandoz, including in a recent Hatch-Waxman case involving a diabetes drug; other victories for Sandoz include a win against Allergan and Duke University regarding its right to launch a generic version of Latisse, a drug used to grow and darken eyelashes. On many of these matters, he joins forces with partners in New York and California, while also drawing on support from associates in Chicago and DC. Kelly Eberspecher is the other local trial supremo to keep on the radar. He has been on a sparkling run of form in inter partes review proceedings, representing Panduit Corp against Corning Optical as both petitioner and patent owner.

Taft Stettinius & Hollister LLP

Taft is a veritable a SWAT team for generic pharmaceutical companies. Pairing up seasoned trial lawyers with PhD-level scientific advisers, the firm has turned Hatch-Waxman litigation into an art form, handling dozens upon dozens of such cases. It also exhibits a deft touch on other crucial instructions, including post-grant proceedings, portfolio evaluation and transactions. At the helm is Stephen Auten, a thought leader and consummate litigator with all-encompassing industry knowledge. On many campaigns he partners with Richard Ruzich, a collaborator cut from the same cloth. For example, the pair are acting for Alkem Laboratories in ANDA litigation involving several generics, with one matter taking on added importance given Alkem’s at-risk launch of the product; they are also a go-to for Apotex, which they represent in litigation and support at the lobbying level.

Winston & Strawn LLP 

A gilt-edged patent litigation firm with which few can compete – whether in Chicago or at the national level – Winston & Strawn has the resources, trial mentality, technical know-how and experience to carry the day in the toughest, highest-exposure cases in any forum. The esteemed firm’s Chicago coverage has increased this year with the addition of Ivan Poullaos to the rankings; clients hail him as a “highly adept litigator who is incredibly effective in developing creative, factually driven legal positions through all phases of a case”. He also has “a great track record in terms of efficiently driving matters and sticking to budgets”. He’s an up-and-coming player in what is undoubtedly one of the most formidable pharmaceutical patent litigation groups around, which is also blessed by the presence of Maureen Rurka and Michael Nutter. Rurka – who, like Poullaos, is another star with a lot of headroom – has deep knowledge of regulatory law which enhances her contentious capabilities. Nutter has this too, and plays a vital role as a strategic counsellor to clients, as well as lead trial lawyer. When occasion demands, he forms a devastatingly effective pairing with George Lombardi, a celebrity of the practice who knocks it out the park when it comes to distilling down complexity to present a clear, compelling case. Lombardi is a prime example of the transferability of high-level trial skills: plentiful though his successes in blockbuster drug cases may be, he also has wins aplenty in other areas to his name. This is true of most all the folks at Winston, including Kurt Mathas, a veteran of many newsworthy life sciences and high-technology patent and antitrust litigations. Michael Brody continues to add new highlights to his litany of high-profile successes in disputes involving communications, semiconductor and other technologies.

Other recommended experts

Few lawyers in the United States have Kenneth R Adamo’s level of strategic perspicacity when it comes to patent litigation, post-grant proceedings and alternative dispute resolution. Consulting him helps any party to sail through the most demanding of cases. Dentons has an elite trial lawyer in Chicago in Timothy Carroll, who has a superlative reputation for his adroit handling of big-ticket cases. He was hired to defend Arthrex in a 22-patent dispute brought by Zimmer Biomet, a major competitor in the orthopaedic medical device space, which put at risk a product line worth more than $100 million in annual revenue; Carroll’s negotiation skills played a huge part in resolving the matter with minimal disruption. David Donoghue captains Holland & Knight’s national IP group and has led it to many notable achievements in patent and IP litigation. He has some high-level matters on his desk right now, and is defending Motorola Mobility and Lenovo against patent infringement claims brought by WiLAN relating to how Motorola Mobility mobile phones operate on cellular networks – the case potentially brings with it significant FRAND and SEP issues. Zareefa Burki Flener has her finger on the pulse of the life sciences and applies keen business instincts to help clients manage and maximise the value of their IP portfolios. The firm she established in 2014, Flener IP & Business Law, is well known for its stellar results and superior client service. A member of the management committee and vice chair of the national IP department, Jeanne Gills is an eminent figure at Foley & Lardner. She has abundant experience across all categories of intellectual property, though is particularly well suited to patent matters, thanks to her technical background. Former Jenner & Block lawyer Sara Tonnies Horton recently joined Willkie Farr & Gallagher. She’s a rising star of the patent litigation and post-grant proceedings scene, with insight beyond her years. Ira Kalina accurately and perceptively reads the innovation and business landscape and moves swiftly to help clients capitalise on patent and technology commercialisation opportunities. The Faegre Drinker partner is highly recommended as a transactional lawyer and relationship builder. Bradford Lyerla is a heavyweight patent litigator who has tried many cases involving cutting-edge technologies to verdict. He joined Tabet DiVito & Rothstein at the start of 2020, having moved on from Jenner & Block, where he spent much of his career. Highly prized by in-house counsel and the C-suite for her strategic and business smarts, Lily Rin-Laures performs flawlessly as a portfolio manager, regulatory lawyer, deal broker and counsellor for life sciences entities. David Rosenbaum of Rosenbaum IP doesn’t do things by rote, but pitches his advice and service perfectly for each client. He dispenses perspicacious counsel on myriad IP matters, including portfolio development and transactions, and seeks to create business value with unwavering focus. “Emer Simic gives clear, constructive and practical advice and is an excellent long-range thinker.” She recently moved from Green, Griffith & Borg-Breen to Neal Gerber Eisenberg. Spence PC is a dynamic IP and litigation boutique whose heart and soul is trial lawyer William Spence. The registered patent attorney, IP commercialisation expert and former Kirkland & Ellis lawyer has strategies at the ready for any complex IP or commercial case. Marcus Thymian recently moved on after 22 years at MBHB to set up GrowIP Law Group. His fine-grained understanding of all facets of patent practice will serve as an excellent platform for this new boutique. A founding partner of Upadhye Tang, Shashank Upadhye is a beacon of light for both branded and generic drug manufacturers, with a profound knowledge of pharmaceutical and Food and Drug Administration law. Having built the global IP department of Apotex, he has valuable in-house experience that has always given him an edge in private practice.

Individuals: litigation

  • Kenneth R Adamo - Law Office of KRAdamo 
  • Richard Cederoth - Sidley Austin LLP
  • James F Hurst - Kirkland & Ellis LLP
  • Russell Levine - Kirkland & Ellis LLP
  • George C Lombardi - Winston & Strawn LLP
  • Bradford P Lyerla - Tabet DiVito & Rothstein LLC
  • David Nelson - Quinn Emanuel Urquhart & Sullivan LLP
  • William A Rakoczy - Rakoczy Molino Mazzochi Siwik LLP
  • Kenneth Schuler - Latham & Watkins LLP
  • Robert W Unikel - Paul Hastings LLP
  • Jason C White - Morgan Lewis & Bockius LLP
  • Michael J Abernathy - Morgan Lewis & Bockius LLP
  • John L Abramic - Steptoe & Johnson LLP
  • Imron T Aly - Schiff Hardin LLP
  • John M Augustyn - Leydig, Voit & Mayer, Ltd
  • Stephen Auten - Taft Stettinius & Hollister LLP
  • Paul H Berghoff - McDonnell Boehnen Hulbert & Berghoff LLP
  • Caryn C Borg-Breen - Green Griffith & Borg-Breen LLP
  • Michael L Brody - Winston & Strawn LLP
  • David K Callahan - Latham & Watkins LLP
  • Christopher V Carani - McAndrews, Held & Malloy Ltd
  • Timothy J Carroll - Dentons
  • Steven Derringer - Bartlit Beck Herman Palenchar & Scott
  • David Donoghue - Holland & Knight LLP
  • Kelly Eberspecher - Steptoe & Johnson LLP
  • James R Ferguson - Mayer Brown
  • Thomas J Filarski - Steptoe & Johnson LLP
  • Kevin M Flowers - Marshall Gerstein & Borun LLP
  • Ralph J Gabric - Haynes and Boone LLP
  • Jeffrey R Gargano - Morgan Lewis & Bockius LLP
  • Robert F Green - Green Griffith & Borg-Breen LLP
  • Bryan S Hales - Kirkland & Ellis LLP
  • Richard Harris - Greenberg Traurig LLP
  • H Michael Hartmann - Leydig, Voit & Mayer, Ltd
  • Reginald J Hill - Jenner & Block LLP
  • Gary E Hood - Polsinelli PC
  • John Hughes - Bartlit Beck Herman Palenchar & Scott
  • John Labbé - Marshall Gerstein & Borun LLP
  • Chris Lind - Bartlit Beck Herman Palenchar & Scott
  • Edward A Mas II - McAndrews, Held & Malloy Ltd
  • Kurt A Mathas - Winston & Strawn LLP
  • Timothy C Meece - Banner Witcoff
  • Laura Beth Miller - Haynes and Boone LLP
  • Paul Molino - Rakoczy Molino Mazzochi Siwik LLP
  • Jay Nuttall - Steptoe & Johnson LLP
  • Michael K Nutter - Winston & Strawn LLP
  • Keith Parr - Locke Lord LLP
  • Sailesh K Patel - Schiff Hardin LLP
  • Thomas D Rein - Sidley Austin LLP
  • Richard T Ruzich - Taft Stettinius & Hollister LLP
  • Matthew Satchwell - DLA Piper
  • Douglas L Sawyer - Perkins Coie LLP
  • James R Sobieraj - Brinks Gilson & Lione
  • Paul R Steadman - DLA Piper
  • Constantine L Trela Jr - Sidley Austin LLP
  • Terrence J Truax - Jenner & Block LLP
  • Steven Trybus - Locke Lord LLP
  • Shashank Upadhye - Upadhye Tang
  • Dominic P Zanfardino - Brinks Gilson & Lione
  • Joseph J Berghammer - Banner Witcoff
  • Daniel J Burnham - Nixon Peabody LLP 
  • Michael P Chu - McDermott Will & Emery
  • John Conklin - Leydig, Voit & Mayer, Ltd
  • James B Coughlan - Perkins Coie LLP
  • Grantland Drutchas - McDonnell Boehnen Hulbert & Berghoff LLP
  • Herbert H Finn - Greenberg Traurig LLP
  • Louis Fogel - Jenner & Block LLP
  • Bruce M Gagala - Leydig, Voit & Mayer, Ltd
  • Jeanne M Gills - Foley & Lardner LLP
  • Christopher Griffith - Green Griffith & Borg-Breen LLP
  • Michael J Harris - Arnold & Porter Kaye Scholer LLP
  • David Headrick - McAndrews, Held & Malloy Ltd
  • Amanda Hollis - Kirkland & Ellis LLP
  • Benjamin T Horton - Marshall Gerstein & Borun LLP
  • Sarah Horton - Willkie Farr & Gallagher
  • Eric Hunt - Rakoczy Molino Mazzochi Siwik LLP
  • Sharon Hwang - McAndrews, Held & Malloy Ltd
  • Mark H Izraelewicz - Marshall Gerstein & Borun LLP
  • John Kilyk Jr - Leydig, Voit & Mayer, Ltd
  • Stephanie Koh - Sidley Austin LLP
  • John S Letchinger - Baker & Hostetler LLP
  • Laura A Lydigsen - Brinks Gilson & Lione
  • Jessica Tyrus Mackay - Green Griffith & Borg-Breen LLP
  • Adam Marchuk - Perkins Coie LLP
  • Deanne M Mazzochi - Rakoczy Molino Mazzochi Siwik LLP
  • Peter J McAndrews - McAndrews, Held & Malloy Ltd
  • J Scott McBride - Bartlit Beck Herman Palenchar & Scott
  • Charles M McMahon - McDermott Will & Emery
  • Sanjay K Murthy - Morgan Lewis & Bockius LLP
  • Kevin M Nelson - Schiff Hardin LLP
  • Binal Patel - Banner Witcoff
  • Ivan M Poullaos - Winston & Strawn LLP
  • Mark H Remus - Brinks Gilson & Lione
  • Christopher J Renk - Arnold & Porter Kaye Scholer LLP
  • Maureen Rurka - Winston & Strawn LLP
  • James Shimota - K&L Gates LLP
  • Leif R Sigmond Jr - Baker & Hostetler LLP
  • Emer Simic - Neal Gerber & Eisenberg LLP
  • William C Spence - SpencePC
  • Robert A Surrette - McAndrews, Held & Malloy Ltd
  • Kent M Walker - Brinks Gilson & Lione
  • Thomas J Wimbiscus - McAndrews, Held & Malloy Ltd
  • Marc Zubick - Latham & Watkins LLP

Individuals: prosecution

  • Robert Barrett - K&L Gates LLP
  • Thomas Basso - K&L Gates LLP
  • Joseph J Berghammer - Banner Witcoff
  • Michael Borella - McDonnell Boehnen Hulbert & Berghoff LLP
  • Daniel J Burnham - Nixon Peabody LLP 
  • Christopher V Carani - McAndrews, Held & Malloy Ltd
  • John Conklin - Leydig, Voit & Mayer, Ltd
  • Zareefa Burki Flener - Flener IP & Business Law 
  • David B Fournier - Perkins Coie LLP
  • Michael P Furmanek - Marshall Gerstein & Borun LLP
  • Janet M Garetto - Nixon Peabody LLP 
  • Troy Groetken - McAndrews, Held & Malloy Ltd
  • Herbert D Hart III - McAndrews, Held & Malloy Ltd
  • Joseph F Hetz - Brinks Gilson & Lione
  • Bradley J Hulbert - McDonnell Boehnen Hulbert & Berghoff LLP
  • Gary R Jarosik - Greenberg Traurig LLP
  • Keith R Jarosik - Greenberg Traurig LLP
  • John Kilyk Jr - Leydig, Voit & Mayer, Ltd
  • Heather Kissling - Marshall Gerstein & Borun LLP
  • Jeremy Kriegel - Marshall Gerstein & Borun LLP
  • Deborah Laughton - McAndrews, Held & Malloy Ltd
  • Charles H Mottier - Leydig, Voit & Mayer, Ltd
  • Michael Muczynski - Marshall Gerstein & Borun LLP
  • Katherine L Neville - Marshall Gerstein & Borun LLP
  • Kevin E Noonan - McDonnell Boehnen Hulbert & Berghoff LLP
  • Binal Patel - Banner Witcoff
  • Wil Rao - McAndrews, Held & Malloy Ltd
  • Li-Hsien (Lily) Rin-Laures - RinLauresLLC
  • David G Rosenbaum - Rosenbaum IP
  • Randall G Rueth - Marshall Gerstein & Borun LLP
  • Ahsan A Shaikh - McDermott Will & Emery
  • Jeffrey S Sharp - Marshall Gerstein & Borun LLP
  • Andrew D Stover - Brinks Gilson & Lione
  • Marcus Thymian - GrowIP Law Group
  • Donald Zuhn - McDonnell Boehnen Hulbert & Berghoff LLP

Individuals: transactions

  • David Berten - Global IP Law Group LLC
  • Pamela L Cox - Marshall Gerstein & Borun LLP
  • C Graham Gerst - Global IP Law Group LLC
  • Russell Levine - Kirkland & Ellis LLP
  • Ragnar Olson - Global IP Law Group LLC
  • Steven Steger - Steger IP, LLC 
  • Thomas J Filarski - Steptoe & Johnson LLP
  • Lara Fitzsimmons - Rakoczy Molino Mazzochi Siwik LLP
  • Robert M Gerstein - Marshall Gerstein & Borun LLP
  • Troy Groetken - McAndrews, Held & Malloy Ltd
  • Marcelo Halpern - Perkins Coie LLP
  • H Michael Hartmann - Leydig, Voit & Mayer, Ltd
  • Neil S Hirshman - Kirkland & Ellis LLP
  • Bradley J Hulbert - McDonnell Boehnen Hulbert & Berghoff LLP
  • Ira Kalina - Faegre Drinker Biddle & Reath LLP
  • Charles H Mottier - Leydig, Voit & Mayer, Ltd
  • Vera Nackovic - Mayer Brown
  • Jeffery S Norman - Kirkland & Ellis LLP
  • Elizabeth Rudersdorf - Steger IP, LLC 
  • Seth Traxler - Kirkland & Ellis LLP
  • Julie M Watson - Marshall Gerstein & Borun LLP


  • Daniel A Boehnen - McDonnell Boehnen Hulbert & Berghoff LLP